For example, Rajakumar et al. defined a 5-miRNA risk score which outperformed the tissue-based PD-L1 staining in predicting overall survival following immunotherapy in advanced NSCLC (Rajakumar et al., 2022). This evidence concerns the gene CD274 and non-small cell lung carcinoma.